Skip to content
★ Sign in to follow
RH
Total declarations
5
Company
1
▲ Purchases (5 ops.)
€107k
▼ Sales (0 ops.)
—

Latest filing published 18 Nov 2019 for Aspira Women's Health Inc., €3,214.

Filing timeline

BuySale
Robert Harry Beechey

Insider track record

Disclosed buys
5
Disclosed sells
0
Signal history

Closed purchases

Market purchases
5
Positive at T+90
40%
Median T+90
-9.3%

Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

Robert Harry Beechey: trading record in brief

Robert Harry Beechey is a declared insider of Aspira Women's Health Inc., with filings sourced from SEC (Form 4). Between 14 August 2018 and 15 November 2019, the trades on record add up to 5 filings.

The open-market record is one-sided, with 5 purchases worth €107k and not one sale. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. 2019 to date brings 2 purchases and no sales.

A typical purchase (the median) is worth €13k. On 1 out of 5 purchases, another insider of the same company was buying within the same 30 days. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase. Looking at 5 purchases old enough to measure, the stock rose over the following 90 days in 40% of cases; the median change was -9.3%. These figures describe past trades and do not predict future prices.

The record was last updated on 18 November 2019 with an open-market purchase (€3,214) in Aspira Women's Health Inc. Half of the filings or more reach the SEC (Form 4) feed on the day of the trade. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Robert Harry Beechey

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations5 total
  • ▲
    Chief Financial OfficerExecutivesAspira Women's Health Inc.
    3,542 USD23SEC
    5,000 shares@ US$0.70833.0% of flowCommon Stock, par value $0.001 per shareSEC:0001725914-19-000003:0
    Canonical exit: 13 Feb 2020 (T+90)
  • ▲
    Chief Financial OfficerExecutivesAspira Women's Health Inc.
    6,300 USD26SEC
    5,000 shares@ US$1.265.3% of flowCommon Stock, par value $0.001 per shareSEC:0001725914-19-000002:0
    Canonical exit: 15 Aug 2019 (T+90)
  • ▲
    Chief Financial OfficerExecutivesAspira Women's Health Inc.
    14,250 USD24SEC
    25,000 shares@ US$0.5711.7% of flowCommon Stock, par value $0.001 per shareSEC:0001725914-18-000004:0
    Canonical exit: 6 Mar 2019 (T+90)
  • ▲
    Chief Financial OfficerExecutivesAspira Women's Health Inc.
    45,750 USD37SEC
    75,000 shares@ US$0.6137.1% of flowCommon Stock, par value $0.001 per shareSEC:0001725914-18-000003:0
    Canonical exit: 21 Nov 2018 (T+90)
  • ▲
    Chief Financial OfficerExecutivesAspira Women's Health Inc.
    52,000 USD23SEC
    100,000 shares@ US$0.5242.9% of flowCommon Stock, par value $0.001 per shareSEC:0001725914-18-000002:0
    Canonical exit: 12 Nov 2018 (T+90)

5 of 5 declarations